Skip to main content
SpringerLink
Log in

Toward Molecular Psychotherapy of Depression?

  • Chapter
  • First Online:
Psychodynamic Psychotherapy Research

Part of the book series: Current Clinical Psychiatry ((CCPSY))

Abstract

The 30–40% share of genetic factors in the disposition to unipolar major depression (MD) leaves an important role for psychosocial and developmental factors in the etiology and treatment of depression [1–3]. Moreover, it is likely that the biological and psychosocial factors are not independent. Their interaction in depression has been suggested in numerous studies, although the relevant mechanisms are not well understood [4–7]. Especially in the psychodynamic picture of depression, the role of somatic factors has been little illuminated due to the lack of a viable theory that would connect somatic signs with the psychodynamic profile of depression [8, 9].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kendler KS, Walters EE, Truett KR, Heeath AC, Neale MC, Martin NG, et al. Sources of individual differences in depressive symptoms: analysis of two samples of twins and their families. Am J Psychiatry. 1994;151:1605–1614.

    PubMed  CAS  Google Scholar 

  2. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157:1552–1562.

    Article  PubMed  CAS  Google Scholar 

  3. Kendler KS, Aggen SH. Time, memory and the heritability of major depression. Psychol Med. 2001;31:923–928.

    PubMed  CAS  Google Scholar 

  4. Kendler KS. Anna-Monika-prize paper. Major depression and the environment: a psychiatric genetic perspective. Pharmacopsychiatry. 1998;31:5–9.

    Article  PubMed  CAS  Google Scholar 

  5. Kendler KS. Explanatory models for psychiatric illness. Am J Psychiatry. 2008;165:695–702.

    Article  PubMed  Google Scholar 

  6. Fanous AH, Neale MC, Aggen SH, Kendler KS. A longitudinal study of personality and major depression in a population-based sample of male twins. Psychol Med. 2007;37:1163–1172.

    Article  PubMed  Google Scholar 

  7. Kendler KS, Campbell J. Interventionist causal models in psychiatry: repositioning the mind-body problem. Psychol Med. 2009;39:881–887.

    Article  PubMed  CAS  Google Scholar 

  8. Luyten P, Blatt SJ, Van Houdenhove B, Corveleyn J. Depression research and treatment: are we skating to where the puck is going to be? Clin Psychol Rev. 2006;26:985–999.

    Article  PubMed  Google Scholar 

  9. Carhart-Harris RL, Mayberg HS, Malizia AL, Nutt D. Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry. Ann Gen Psychiatry. 2008;7:9. Published online 24 July 2008.doi: 10.1186/1744–859X-7–9.

    Article  PubMed  Google Scholar 

  10. Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry. 2000;57(4):375–380.

    Article  PubMed  CAS  Google Scholar 

  11. Keller MC, Neale MC, Kendler KS. Association of different adverse life events with distinct patterns of depressive symptoms. Am J Psychiatry. 2007;164(10):1521–29.

    Article  PubMed  Google Scholar 

  12. Busch FN, Rudden M, Shapiro T. Psychodynamic treatment of depression: development of a psychodynamic model of depression. Arlington: American Psychiatric Publishing; 2004. p. 13–30.

    Google Scholar 

  13. Morgan N, Taylor T. Psychodynamic psychotherapy and treatment of depression. Psychiatry. 2005;4(5):6–9.

    Article  Google Scholar 

  14. Taylor D, Richardson P. The psychoanalytic/psychodynamic approach to depressive disorder. In: Gabbard GO, Beck SJ, Holmes J, editors. Oxford textbook of psychiatry. Oxford: Oxford University Press; 2005. p. 127–136.

    Google Scholar 

  15. Luutonen S. Anger and depression – theoretical and clinical considerations. Nord J Psychiatry. 2007;1(4):246–251.

    Article  Google Scholar 

  16. Lux V, Kendler KS. Deconstructing major depression: a validation study of the DSM-IV symptomatic criteria. Psychol Med. 2010;40:1–12.

    Article  Google Scholar 

  17. Mayberg HS. Targeted electrode-based modulation of neural circuits for depression. J Clin Invest. 2009;119: 717–725.

    Article  PubMed  CAS  Google Scholar 

  18. Nemeroff CB, Owens MJ. The role of serotonin in the pathophysiology of depression: as important as ever. Clin Chem. 2009;55:1578–1579.

    Article  PubMed  CAS  Google Scholar 

  19. Wampold BE. The great psychotherapy debate. New Jersey: Lawrence Erlbaum; 2001.

    Google Scholar 

  20. Shelder J. The efficacy of psychodynamic psychotherapy. Am Psychol. 2010;65:98–109.

    Article  Google Scholar 

  21. Meltzer HY. Role of serotonin in depression. Ann N Y Acad Sci. 1990;600:486–499.

    Article  PubMed  CAS  Google Scholar 

  22. Tiihonen J, Kuoppamäki M, Någren K, Bergmand J, Eronen E, Syvälahti E, et al. Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography. Psychopharmacology. 1996;126:277–280.

    Article  PubMed  CAS  Google Scholar 

  23. Young EA, Aggen SH, Prescott CA, Kendler KS. Similarity in saliva cortisol measures in monozygotic twins and the influence of past major depression. Biol Psychiatry. 2000;48:70–74.

    Article  PubMed  CAS  Google Scholar 

  24. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry. 2002;159:728–737.

    Article  PubMed  Google Scholar 

  25. Tafet GE, Idoyaga-Vargas VP, Abulafia DP, Calandria JM, Roffman SS, Chiovetta A, et al. Correlation between cortisol level and serotonin uptake in patients with chronic stress and depression. Cogn Affect Behav Neurosci. 2001;1:388–393.

    Article  PubMed  CAS  Google Scholar 

  26. Hettema JM, An SS, van der Oord EJ, Neale MC, Kendler KS, Chen X. Association study between 1A receptor (HTR1A) gene and neuroticism, major depression, and anxiety disorders. Am J Med Genet B: Neuropsychiatr Genet. 2008;147B:661–666.

    Article  CAS  Google Scholar 

  27. Castrén E. Is mood chemistry? Nat Rev Neurosci. 2005;6(3):241–6.

    Article  PubMed  Google Scholar 

  28. Maya Vetencourt JF, Sale A, Viegi A, Baroncelli L, De Pasquale R, O’Leary OF, et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science. 2008;320(5874):385–8.

    Article  PubMed  CAS  Google Scholar 

  29. Damasio A. Looking for Spinoza: joy, sorrow and the feeling brain. London: Vintage; 2003.

    Google Scholar 

  30. Panksepp J. Affective neuroscience. Oxford: Oxford University Press; 1998.

    Google Scholar 

  31. Freud FS. The ego and the Id. 1923. Standard ed. London: Hogarth Press; 1963. p. 3–66.

    Google Scholar 

  32. Lehtonen J, Partanen J, Purhonen M, Valkonen-Korhonen M, Könönen M, Saarikoski S, et al. Nascent body ego. Metapsychological and neurophysiological aspects. Int J Psychoanal. 2006;87:1335–1353.

    Article  PubMed  Google Scholar 

  33. Solms A, Turnbull O. The brain and the inner world. London: Karnac; 2002.

    Google Scholar 

  34. Edelman G. Second nature. Brain science and human knowledge. New Haven: Yale University Press; 2006.

    Google Scholar 

  35. Watt D. Toward a neuroscience of empathy: integrating affective and cognitive perspectives. Neuro-Psychoanal. 2007;8:119–40.

    Google Scholar 

  36. Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. Electroenceph Clin Neurophysiol. 1949;1:455–473.

    PubMed  CAS  Google Scholar 

  37. Magoun HW. The waking brain. Springfield: Charles C. Thomas; 1965.

    Google Scholar 

  38. LeDoux J. The emotional brain. New York: Simon and Schuster; 1996.

    Google Scholar 

  39. Craig AD. Pain as an interoceptive aspect of homeostasis. In: Kalso E, Estlander A-M, Klockars M, editors. Psyche, soma and pain, Acta Gyllenbergiana. Helsinki: The Signe and Ane Gyllenberg Foundation; 2003. p. 161–172.

    Google Scholar 

  40. Raij TT, Valkonen-Koronen M, Holi M, Therman S, Lehtonen J, Hari R. Reality of auditory verbal hallucinations. Brain. 2009;132:2994–3001.

    Article  PubMed  Google Scholar 

  41. Truex RC, Carpenter MB. Human neuroanatomy. 6th ed. Baltimore: Williams & Wilkins; 1969.

    Google Scholar 

  42. Dougherty DD, Rauch SL, Deckersbach T, Marci C, Loh R, Shin LM, et al. Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks. Arch Gen Psychiatry. 2004;61:795–804.

    Article  PubMed  Google Scholar 

  43. Frokjaer VG, Vinberg M, Erritzoe D, et al. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding. Neuroimage. 2009;46:360–366.

    Article  PubMed  Google Scholar 

  44. Liotti M, Mayberg HS, Brannan SK, McGinnis S, Jerabek P, Fox PT. Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders. Biol Psychiatry. 2000;48:30–42.

    Article  PubMed  CAS  Google Scholar 

  45. Thomas EJ, Elliott R. Brain imaging correlates of cognitive impairment in depression. Front Hum Neurosci. 2009;3:1–9.

    Google Scholar 

  46. Cannon DM, Ichise M, Rollis D, et al. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biol Psychiatry. 2007;62:870–877.

    Article  PubMed  CAS  Google Scholar 

  47. Damasio AR. Descartes’ error. London: Macmillan; 1996.

    Google Scholar 

  48. Roffman JL, Marci CD, Glick DM, Dougherty DD, Rauch SL. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol Med. 2005;35(10):1385–98.

    Article  PubMed  Google Scholar 

  49. Linden DEJ. How psychotherapy changes the brain – the contribution of functional neuroimaging. Mol Psychiatry. 2006;11:528–38.

    Article  PubMed  CAS  Google Scholar 

  50. Beauregard M. Effect of mind on brain activity: evidence from neuroimaging studies of psychotherapy. Nord J Psychiatry. 2009;63:5–16.

    Article  PubMed  Google Scholar 

  51. Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush JA, Schatzberg AF, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci USA. 2003;100:14293–14296.

    Article  PubMed  CAS  Google Scholar 

  52. Kuikka JT, Tenhunen-Eskelinen M, Jurvelin J, Kiilianen H. Physical performance of the Siemens MultiSPECT 3 gamma camera. Nucl Med Commun. 1993;14:490–497.

    Article  PubMed  CAS  Google Scholar 

  53. Tiihonen J, Kuikka JT, Bergström KA, Karhu J, Viinamäki H, Lehtonen J, et al. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. Eur J Nucl Med. 1997;24:1253–1260.

    Article  PubMed  CAS  Google Scholar 

  54. Tiihonen J, Kuikka J, Viinamäki H, Lehtonen J, Partanen J. Altered cerebral blood flow during hysterical paresthesia. Biol Psychiatry. 1995;37:134–135.

    Article  PubMed  CAS  Google Scholar 

  55. Hiltunen J, Akerman KK, Kuikka JT, et al. Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography. Eur J Nucl Med. 1998;25: 2728.

    Google Scholar 

  56. Viinamäki H, Kuikka J, Tiihonen J, Lehtonen J. Change in monoamine transporter density related to clinical recovery: a case–control study. Nord J Psychiatry. 1998;52:39–44.

    Article  Google Scholar 

  57. Saarinen PI, Lehtonen J, Joensuu M, Tolmunen T, Ahola P, Vanninen R, et al. An outcome of psychodynamic psychotherapy: a case study of the change in serotonin transporter binding and the activation of the dream screen. Am J Psychother. 2005;59(1):61–73.

    PubMed  Google Scholar 

  58. Tolmunen T, Joensuu M, Saarinen PI, Mussalo H, Ahola P, Vanninen R, et al. Elevated midbrain serotonin availability in mixed mania: a case report. BMC Psychiatry. 2004;4(13):27.

    Article  PubMed  Google Scholar 

  59. Laasonen-Balk T, Viinamäki H, Kuikka JT, Husso-Saastamoinen M, Lehtonen J, Tiihonen J. 123I-β CIT binding and recovery from depression. A six month follow-up study. Eur Arch Psychiatr Clin Neurosci. 2004;254: 152–155.

    Google Scholar 

  60. Malison RT, Price LH, Berman R, et al. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 betacarbomethoxy-3 beta-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry. 1998;44:1090–1098.

    Article  PubMed  CAS  Google Scholar 

  61. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.

    Google Scholar 

  62. Joensuu M, Tolmunen T, Saarinen PI, Tiihonen J, Kuikka J, Ahola P, et al. Reduced midbrain serotonin transporter availability in drug naive patients with depression measured by SERT-specific [(123) I] nor-beta-CIT SPECT imaging. Psychiatry Res. 2007;154(2):125–131.

    Article  PubMed  CAS  Google Scholar 

  63. Joensuu M, Lehto SM, Tolmunen T, Saarinen PI, Valkonen-Korhonen M, Vanninen R, et al. 5-HTTLPR polymorphism and serotonin transporter binding in drug-naïve patients with major depression. Psychiatry Clin Neurosci. 2010;64:387–393.

    Article  PubMed  CAS  Google Scholar 

  64. Lehto SM, Tolmunen T, Joensuu M, et al. Midbrain binding of [123I]nor-beta-CIT in atypical depression. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1251–1255.

    Article  PubMed  CAS  Google Scholar 

  65. Lehto SM, Tolmunen T, Kuikka J, Valkonen-Korhonen M, Joensuu M, Saarinen PI, et al. Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study. Neurosci Lett. 2008; 441:291–295.

    Article  PubMed  CAS  Google Scholar 

  66. Lehto SM, Tolmunen T, Joensuu M, Saarinen PI, Valkonen-Korhonen M, Vanninen R, et al. Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):229–37.

    Article  PubMed  CAS  Google Scholar 

  67. Stewart JW, McGrath P, Rabkin J, QuitKin FM. Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacol. 1998;18:429–34.

    Article  PubMed  CAS  Google Scholar 

  68. Parker G, Roy K, Mitchell P, Wilhelm K, Malhi G, Hadci-Pavlovic D. Atypical depression: a reappraisal. Am J Psychiatry. 2002;159:1470–1479.

    Article  PubMed  Google Scholar 

  69. Karlsson H, Hirvonen J, Kajander J, Markkula J, Rasi-Hakala H, Salminen JK, et al. Psychotherapy increases brain serotonin 5-HT1A receptors in patients with major depressive disorder. Psychol Med. 2010;40(3):523–8.

    Article  PubMed  CAS  Google Scholar 

  70. Drevets WC, Thase M, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, et al. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol. 2007;34:865–877.

    Article  PubMed  CAS  Google Scholar 

  71. Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord. 1998;51:215–235.

    Article  PubMed  CAS  Google Scholar 

  72. Krupnick JL, Sotsky SM, Simmens S, Moyer J, Elkin I, Watkins J, et al. The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1996;64(3):532–539.

    Article  PubMed  CAS  Google Scholar 

  73. Ahola P, Valkonen-Korhonen M, Tolmunen T, Joensuu M, Lehto SM, Saarinen PI, et al. The perceptions of patients and their therapists of the process of psychodynamic psychotherapy for depression. Am J Psychotherapy 2011;65: (in press).

    Google Scholar 

  74. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389.

    Article  PubMed  CAS  Google Scholar 

  75. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry. 2005;62:529–5340.

    Article  PubMed  CAS  Google Scholar 

  76. Risch N, Herrell R, Lehner T, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events and risk of depression: a meta-analysis. JAMA. 2009;301:2462–2471.

    Article  PubMed  CAS  Google Scholar 

  77. Kandel E. In search of memory: the emergence of a new science of mind. New York: WW Norton; 2006.

    Google Scholar 

  78. Akil H, Brenner S, Kandel E, Kendler KS, King M-C, Scolnick E, et al. The future of psychiatric research: genomes and neural circuits. Science. 2010;327:1580–1581.

    Article  PubMed  Google Scholar 

  79. Portin P, Lehtonen J, Alanen YO. Mental illness requires a multidisciplinary research plan. Science. 2010; 328:1229.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Eastern Finland, University Hospital of Kuopio, Kuopio, Finland

    Johannes Lehtonen M.D., Ph.D., Soili M. Lehto M.D., Ph.D., Pasi Olavi Ahola M.D. & Pirjo Irmeli Saarinen M.D., Ph.D.

  2. Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland

    Jari Tiihonen M.D., Ph.D. & Mikko Martti Oskari Joensuu M.D.

  3. Department of Psychiatry, University of Eastern Finland, Kuopio, Finland

    Minna Valkonen-Korhonen M.D.

  4. Department of Adolescent Psychiatry, Kuopio University Hospital, Kuopio, Finland

    Tommi Tolmunen M.D., Ph.D.

  5. Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland

    Jyrki T. Kuikka Ph.D.

Authors
  1. Johannes Lehtonen M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jari Tiihonen M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mikko Martti Oskari Joensuu M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Soili M. Lehto M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pasi Olavi Ahola M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pirjo Irmeli Saarinen M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Minna Valkonen-Korhonen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tommi Tolmunen M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jyrki T. Kuikka Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johannes Lehtonen M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Harvard Medical School, Department of Psychiatry, Parkman St., Boston, 02114, Massachusetts, USA

    Raymond A. Levy

  2. Massachusetts General Hospital, Harvard Medical School, Department of Psychiatry, Morrimac Street 101, Boston, 02114, Massachusetts, USA

    J. Stuart Ablon

  3. and Psychoanalysis, International Psychoanalytic University, Department of Clinical Psychology, Stromstr. 3, Berlin, 10555, Germany

    Horst Kächele

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Lehtonen, J. et al. (2012). Toward Molecular Psychotherapy of Depression?. In: Levy, R., Ablon, J., Kächele, H. (eds) Psychodynamic Psychotherapy Research. Current Clinical Psychiatry. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-792-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-792-1_12

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-791-4

  • Online ISBN: 978-1-60761-792-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation